Bizmoon
Grants & Loans
Regulations
Industries
Sign in
Learn more
Bizmoon

Product

  • Grants
  • Regulations
  • License checker
  • Guides
  • How it works
  • Pricing
  • Blog

Industries

  • Healthcare
  • Trade and Commerce
  • Transportation and Logistics
  • Energy and Utilities
  • Finance and Banking
  • Land and Natural Resources
  • Agriculture

Coverage

  • All grants
  • All regulations
  • Federal grants
  • Federal regulations

Company

  • Careers
  • Sign in
© 2026 BizmoonPrivacyTermsCredits
  1. Home
  2. Regulations
  3. Federal

Federal regulations

Agency
  • SEC229
  • HHS221
  • DOC218
  • DOT211
  • FDA194
  • DOE160
DHS
154
  • FERC142
  • FAA111
  • EPA92
  • DOJ73
  • NOAA68
  • USDA65
  • Treasury64
  • NIH56
  • DOL47
  • FCC29
  • SBA29
  • HUD22
  • CMS18
  • IRS16
  • FTC4
  • Topic
    • Compliance5
    • Operations3
    • Product3
    • Product Development2
    • Business Development1
    • Finance1
    • Sales1
    • Supply Chain1
    Recency
    • Last 30 days
    • Last 7 days
    CMSRemove filter: CMSDOLRemove filter: DOLEPARemove filter: EPAFAARemove filter: FAAFDARemove filter: FDAFTCRemove filter: FTCHHSRemove filter: HHSHUDRemove filter: HUDNIHRemove filter: NIHUSDARemove filter: USDAClear all
    • Expedited Investigational New Drug Pilot Program; Request for Information; Correction
      July 6, 2026

      FDA corrects contact information for the Expedited Investigational New Drug Pilot Program docket, which solicits public input on shortening timelines from drug identification to first-in-human clinical trials.

    • Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Approval of Medical Devices
      July 6, 2026

      The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.

    • Determination That VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, Injection, 50 units/50 milliliters (1 unit/milliliters) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
    Page 1 of 69 (684 total)Next

    Track Federal regulations for your business

    Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.

    Action items + deadlines

    Every rule is broken into specific to-dos with calendar dates.

    Affected areas

    We tell you which parts of your business each rule actually touches.

    Plain-English summaries

    Healthcare draws more federal rulemaking than any other sector

    After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.

    Federal rulemaking

    • Healthcare and life sciences
    • Trade and commerce
    • Transportation and aviation
    • Energy and utilities
    • Finance
    • Natural resources
    • Other

    Browse by agency

    • CMS
    • DHS
    • DOC
    • DOE
    • DOJ
    • DOL

    Browse by state

    • Arizona
    • California
    • Colorado
    • Florida
    • Illinois
    • Kentucky
    July 6, 2026

    FDA determines that vasopressin 0.9% injection was not withdrawn for safety or effectiveness reasons, allowing approval of generic abbreviated new drug applications if other regulatory requirements are met.

  • Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I; Request for Information
    July 6, 2026

    The Office of the Assistant Secretary for Health seeks public comments on a proposed threshold for scheduling 7-hydroxymitragynine under the Controlled Substances Act.

  • Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
    July 6, 2026

    FDA withdraws approval of 34 new drug applications across multiple applicants whose manufacturers requested withdrawal due to discontinued marketing.

  • Submission for OMB Review; Comment Request
    July 6, 2026

    I need the description to create an accurate summary. Please provide the description field for this OMB submission document.

  • Information Collection Request; General Program Administration
    July 6, 2026

    Farm Service Agency seeks public comments on a revised information collection for General Program Administration to verify applicant eligibility, authorized loan use, and government security interests under the Paperwork Reduction Act.

  • Submission for OMB Review; Comment Request
    July 6, 2026

    OMB review process for federal regulations requires public comment submissions; the comment period deadline and specific regulatory details are not specified in the title alone.

  • Privacy Act of 1974; Matching Program
    July 6, 2026

    Centers for Medicare & Medicaid Services launches a matching program with the Department of Veterans Affairs to verify eligibility for insurance affordability programs under the Affordable Care Act.

  • Agency Forms Undergoing Paperwork Reduction Act Review
    July 6, 2026

    Multiple federal agency forms are undergoing Paperwork Reduction Act review to assess and potentially reduce reporting burdens on small businesses and other respondents.

  • No legal jargon. Read the impact in two sentences.

    Real-time alerts

    Email + dashboard pings the moment something changes.

    Get started free
  • DOT
  • EPA
  • FAA
  • FCC
  • FDA
  • FERC
  • FTC
  • HHS
  • HUD
  • IRS
  • NIH
  • NOAA
  • SBA
  • SEC
  • Treasury
  • USDA
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Missouri
  • New York
  • North Carolina
  • Ohio
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Texas
  • Virginia
  • Washington
  • Wisconsin
  • Federal grants